Chronic Rhinosinusitis With Nasal Polyps Clinical Trial
Official title:
Real Life Assessment of Biologics Efficacy in Severe Chronic Rhinosinusitis With Nasal Polyps
With a prevalence of 2-4% in western countries, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) is of major concern regarding its substantial impact on the social and physical quality of life. So far, endoscopic sinus surgery remains the treatment of choice when the first line of medical treatment with corticosteroid has failed. During the last 15 years, several studies have shown that CRSwNP is associated with a T helper 2 (T2) immune response leading to B cell release of IgE, mucosal recruitment of eosinophils from bone marrow via Interleukin (IL)-5, IL-4 and IL-13 mediated chemoattractant production. New biologic agents capable of blocking T2 cytokines have been developed in the field of eosinophil-associated diseases, shifting the paradigm of treatment for patients with CRSwNP. In the near future, endotype profiling with accurate biomarkers will be mandatory to tailor the treatment of nasal polyposis with specific biologic therapies. Herein we propose a prospective study monitoring medical records of CRSwNP patients who undergo biologic treatments. The objectives are to assess treatment efficacy on quality of life, to report clinical and biological criteria for prescription and to measure tolerance and compliance.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05895929 -
The Role of IL5 in Epithelial Cell Integrity
|
Early Phase 1 | |
| Active, not recruiting |
NCT05891483 -
Efficacy and Safety of SHR-1905 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps
|
Phase 2 | |
| Active, not recruiting |
NCT04998604 -
EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients
|
Phase 4 | |
| Recruiting |
NCT06069310 -
Mepolizumab Effectiveness in Patients With Chronic Rhinosinusitis, Nasal Polyps and Comorbid Severe Eosinophilic Asthma
|
||
| Recruiting |
NCT05009758 -
Moving Towards Precision Medicine in United Airways Disease: Unraveling Inflammatory Patterns in Asthmatic Patients With or Without Nasal Polyps
|
N/A | |
| Active, not recruiting |
NCT05529784 -
Dupilumab in the Treatment of Severe Uncontrolled CRSwNP: a Multicentre Observational Real-life Study (DUPIREAL)
|
||
| Recruiting |
NCT05902325 -
Identifying Predictors Of Response To Mepolizumab In CRSwNP
|
Phase 4 | |
| Completed |
NCT05049122 -
Dupilumab in Japanese Patients With Chronic Rhinosinusitis With Nasal Polyp (SINUS-M52)
|
Phase 4 | |
| Not yet recruiting |
NCT05598411 -
CST1-Guided Oral Glucocorticoids Management for CRSwNP
|
Phase 4 | |
| Active, not recruiting |
NCT05553951 -
Adherence in Global Airways
|
N/A | |
| Recruiting |
NCT05131464 -
The Study of CM310 in Patients With Chronic Rhinosinusitis With Nasal Polyps
|
Phase 2 | |
| Recruiting |
NCT05598424 -
CST1 Predictive Model of Oral Glucocorticoid Therapy Sensitivity for Chronic Rhinosinusitis With Polyps
|
Phase 4 | |
| Active, not recruiting |
NCT05649813 -
A Study in Male and Female Adult Participants With Chronic Rhinosinusitis With Nasal Polyps In the Greater Gulf Region
|
||
| Recruiting |
NCT04628442 -
Tissue Immune Interaction in Nasal Polyposis
|
||
| Active, not recruiting |
NCT06118554 -
3D Printing to Improve Nasal Irrigation Outcome
|
N/A | |
| Active, not recruiting |
NCT04596189 -
Dupilumab for Prevention of Recurrence of CRSwNP After ESS
|
Phase 4 | |
| Recruiting |
NCT02668861 -
Effect of Oral Vitamin D3 on Chronic Rhinosinusitis Treatment in Adults With Lower Vitamin D Levels
|
Phase 3 | |
| Active, not recruiting |
NCT05878093 -
Dupilumab in Chinese Adult Participants With CRSwNP
|
Phase 3 | |
| Completed |
NCT05931744 -
The Role of Budesonide Intrapolyp Injection in the Management of Type 2 Chronic Rhinosinusitis
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05938972 -
Real Life Study of Biologicals in Patients With Severe CRSwNP
|